CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact
Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: ANAPC5 (ImmuneEditome ID:51433)

1. Gene summary of enriched editing regions for ANAPC5

check button Gene summary
Gene informationGene symbol

ANAPC5

Gene ID

51433

GeneSynonymsAPC5
GeneCytomap

12q24.31

GeneTypeprotein-coding
GeneDescriptionanaphase-promoting complex subunit 5|cyclosome subunit 5
GeneModificationdate20230329
UniprotIDQ9UJX4;F5H0F9;F5H3S5;F5GZ05;F5GY68;F5H0N1
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chr12:121311596-121312817:-ENST00000534976.4ENSG00000089053.11ANAPC5ncRNA_intronicAluSc8,L1MB5,AluJr,AluSxchr12:121311596-121312817:-.alignment
chr12:121311596-121312817:-ENST00000535641.4ENSG00000089053.11ANAPC5ncRNA_intronicAluSc8,L1MB5,AluJr,AluSxchr12:121311596-121312817:-.alignment
chr12:121311596-121312817:-ENST00000544314.4ENSG00000089053.11ANAPC5ncRNA_intronicAluSc8,L1MB5,AluJr,AluSxchr12:121311596-121312817:-.alignment
chr12:121313191-121314913:-ENST00000534976.4ENSG00000089053.11ANAPC5ncRNA_intronicAluSz6,L1MB5,AluSz,AluSq2chr12:121313191-121314913:-.alignment
chr12:121313191-121314913:-ENST00000535641.4ENSG00000089053.11ANAPC5ncRNA_intronicAluSz6,L1MB5,AluSz,AluSq2chr12:121313191-121314913:-.alignment
chr12:121313191-121314913:-ENST00000544314.4ENSG00000089053.11ANAPC5ncRNA_intronicAluSz6,L1MB5,AluSz,AluSq2chr12:121313191-121314913:-.alignment
chr12:121331840-121335482:-ENST00000538334.1ENSG00000089053.11ANAPC5ncRNA_exonic(TTCTT)n,Charlie19a,L2a,L3,AluSq2,AluSx,AluJb,AluJrchr12:121331840-121335482:-.alignment
chr12:121338457-121339588:-ENST00000534976.4ENSG00000089053.11ANAPC5ncRNA_intronicHAL1b,AluSg,AluSz,AluSx1chr12:121338457-121339588:-.alignment
chr12:121338457-121339588:-ENST00000539612.4ENSG00000089053.11ANAPC5ncRNA_intronicHAL1b,AluSg,AluSz,AluSx1chr12:121338457-121339588:-.alignment
chr12:121338457-121339588:-ENST00000541652.4ENSG00000089053.11ANAPC5ncRNA_intronicHAL1b,AluSg,AluSz,AluSx1chr12:121338457-121339588:-.alignment


Top

2. Tumor-specific enriched editing regions for ANAPC5


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot
chr12:121331840-121335482:-KIRPCliEER9.0273e-036.3867e-040.6056image
ENSG00000089053.11,ANAPC5KIRPCliEAG3.2923e-031.9414e-040.6208image


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot

Top

3. Enriched editing regions and immune related genes for ANAPC5


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
chr12:121331840-121335482:-LAMLEERENSG00000117899,MESDC2-0.39867.0130e-033.9125e-07-0.4026imageNCELF2;CNBP;DDX54;DHX9;EIF4A3;ELAVL1;FBL;FUS;HNRNPA1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;IGF2BP2;KHDRBS2;KHDRBS3;NOP56;NOP58;PTBP1;RBFOX2;RBM47;SF3A3;SLTM;SRSF1;SRSF3;SRSF7;TARDBP;U2AF2;YTHDF1NAMast_cells_restingGSVA_HALLMARK_TNFA_SIGNALING_VIA_NFKB
chr12:121331840-121335482:-LAMLEERENSG00000213362,FTH1P120.33912.9280e-024.6393e-080.4307imageNNNAMacrophages_M1GSVA_HALLMARK_COMPLEMENT
chr12:121331840-121335482:-LAMLEERENSG00000232187,FTH1P70.32404.0005e-022.4051e-080.4389imageNNNAMonocytesGSVA_HALLMARK_COMPLEMENT
chr12:121331840-121335482:-LAMLEERENSG00000234975,FTH1P20.32064.4198e-023.5389e-070.4040imageNNNAMacrophages_M1GSVA_HALLMARK_PANCREAS_BETA_CELLS
chr12:121331840-121335482:-LAMLEERENSG00000135334,AKIRIN20.32334.5930e-021.8410e-080.4422imageNCELF2;CNBP;DDX54;DHX9;EIF4A3;ELAVL1;FBL;FUS;HNRNPA1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;IGF2BP2;KHDRBS2;KHDRBS3;NOP56;NOP58;PTBP1;RBFOX2;RBM47;SF3A3;SLTM;SRSF1;SRSF3;SRSF7;TARDBP;U2AF2;YTHDF1AKIRIN2MonocytesGSVA_HALLMARK_TNFA_SIGNALING_VIA_NFKB

More results



Top

4. Enriched editing regions and immune related splicing for ANAPC5


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
chr12:121331840-121335482:-
ESCAEERA3ENSG00000121900.14chr132895909:32895969:32895554:32895644:32895554:32895733-0.11984.4237e-026.0026e-06-0.4148imageNDDX54;EIF4A3;FBL;FUS;HNRNPA1;HNRNPM;IGF2BP2;NOP58;RBFOX2;SRSF1;U2AF2;YTHDF1NAGSVA_HALLMARK_ALLOGRAFT_REJECTION

More results



Top

5. Enriched editing regions and immune infiltration for ANAPC5


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
chr12:121331840-121335482:-BLCAEERNeutrophils1.2598e-020.4296image
ENSG00000089053.11,ANAPC5BLCAEAGB_cells_memory3.6925e-030.4154image
chr12:121331840-121335482:-CESCEERNeutrophils3.0014e-020.4344image
ENSG00000089053.11,ANAPC5CESCEAGNeutrophils3.0413e-030.4624image
chr12:121331840-121335482:-COADEERMast_cells_resting1.3708e-020.3732image
ENSG00000089053.11,ANAPC5COADEAGDendritic_cells_activated2.3419e-020.3267image
chr12:121311596-121312817:-ESCAEERMacrophages_M01.1294e-020.2785image
chr12:121313191-121314913:-ESCAEERT_cells_CD4_memory_resting3.9118e-02-0.2649image
ENSG00000089053.11,ANAPC5ESCAEAGT_cells_CD4_naive1.2326e-020.2165image
chr12:121331840-121335482:-GBMEERT_cells_CD4_memory_activated9.2678e-030.4166image
ENSG00000089053.11,ANAPC5GBMEAGT_cells_CD4_memory_activated2.4802e-040.5425image
chr12:121331840-121335482:-KIRCEERMonocytes3.9949e-020.1936image
ENSG00000089053.11,ANAPC5KIRCEAGMacrophages_M05.5138e-03-0.2529image
ENSG00000089053.11,ANAPC5KIRPEAGDendritic_cells_resting2.0462e-02-0.3118image
chr12:121331840-121335482:-LAMLEERMonocytes1.0800e-020.2090image
ENSG00000089053.11,ANAPC5LAMLEAGMonocytes2.9659e-030.2410image
chr12:121331840-121335482:-LGGEERMast_cells_activated2.2742e-020.1410image
ENSG00000089053.11,ANAPC5LGGEAGMast_cells_activated2.2492e-020.1412image
ENSG00000089053.11,ANAPC5LUADEAGMast_cells_resting2.8998e-020.2278image
chr12:121331840-121335482:-LUSCEERT_cells_CD83.9586e-020.2127image
ENSG00000089053.11,ANAPC5LUSCEAGDendritic_cells_activated2.3332e-02-0.2036image
chr12:121331840-121335482:-OVEERMacrophages_M22.4604e-020.1913image
ENSG00000089053.11,ANAPC5OVEAGMacrophages_M14.2852e-02-0.1598image
chr12:121331840-121335482:-PCPGEERDendritic_cells_activated5.9420e-030.5669image
ENSG00000089053.11,ANAPC5PCPGEAGDendritic_cells_activated5.9420e-030.5669image
chr12:121331840-121335482:-PRADEERMacrophages_M03.0801e-020.2889image
ENSG00000089053.11,ANAPC5SARCEAGNK_cells_resting3.9595e-020.3227image
chr12:121331840-121335482:-SKCMEERNeutrophils1.4342e-040.5076image
ENSG00000089053.11,ANAPC5SKCMEAGNK_cells_activated1.3357e-030.4183image
chr12:121311596-121312817:-STADEERT_cells_CD4_memory_activated4.0691e-020.1929image
chr12:121313191-121314913:-STADEERPlasma_cells3.4676e-03-0.3292image
chr12:121331840-121335482:-STADEERNK_cells_resting5.2520e-030.1863image
chr12:121338457-121339588:-STADEERDendritic_cells_activated1.5209e-030.4589image
ENSG00000089053.11,ANAPC5STADEAGNK_cells_resting4.1323e-030.1826image
ENSG00000089053.11,ANAPC5TGCTEAGNeutrophils3.2305e-020.4380image
chr12:121331840-121335482:-THYMEERT_cells_CD4_memory_resting1.8365e-020.5215image
ENSG00000089053.11,ANAPC5THYMEAGMast_cells_resting2.0593e-020.4901image


Top

6. Enriched editing regions and immune gene sets for ANAPC5


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot
chr12:121331840-121335482:-STADEER4.4543e-030.18981.5525e-020.16191.3019e-020.16618.4116e-040.2220image


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
ENSG00000089053.11,ANAPC5BLCAGSVA_HALLMARK_HEME_METABOLISMEAG4.8261e-030.4043image
chr12:121331840-121335482:-BLCAGSVA_HALLMARK_PEROXISOMEEER8.1137e-030.4530image
chr12:121331840-121335482:-BRCAGSVA_HALLMARK_PANCREAS_BETA_CELLSEER5.7802e-040.2089image
ENSG00000089053.11,ANAPC5BRCAGSVA_HALLMARK_PANCREAS_BETA_CELLSEAG9.2510e-050.2245image
chr12:121331840-121335482:-CESCGSVA_HALLMARK_PANCREAS_BETA_CELLSEER3.1488e-02-0.4310image
ENSG00000089053.11,ANAPC5CESCGSVA_HALLMARK_CHOLESTEROL_HOMEOSTASISEAG3.8957e-020.3320image
ENSG00000089053.11,ANAPC5ESCAGSVA_HALLMARK_APICAL_JUNCTIONEAG2.5367e-020.1938image
chr12:121331840-121335482:-ESCAGSVA_HALLMARK_P53_PATHWAYEER1.4592e-020.2207image
ENSG00000089053.11,ANAPC5GBMGSVA_HALLMARK_GLYCOLYSISEAG7.3820e-030.4124image
chr12:121331840-121335482:-GBMGSVA_HALLMARK_PANCREAS_BETA_CELLSEER1.2196e-020.4027image
ENSG00000089053.11,ANAPC5KIRCGSVA_HALLMARK_FATTY_ACID_METABOLISMEAG2.6401e-050.3750image
chr12:121331840-121335482:-KIRCGSVA_HALLMARK_XENOBIOTIC_METABOLISMEER2.7883e-040.3356image
chr12:121331840-121335482:-KIRPGSVA_HALLMARK_UV_RESPONSE_UPEER4.3215e-02-0.2843image
ENSG00000089053.11,ANAPC5KIRPGSVA_HALLMARK_DNA_REPAIREAG3.8097e-02-0.2804image
chr12:121331840-121335482:-LAMLGSVA_HALLMARK_TNFA_SIGNALING_VIA_NFKBEER1.6138e-040.3053image
ENSG00000089053.11,ANAPC5LAMLGSVA_HALLMARK_TNFA_SIGNALING_VIA_NFKBEAG8.2360e-050.3159image
ENSG00000089053.11,ANAPC5LGGGSVA_HALLMARK_BILE_ACID_METABOLISMEAG4.0995e-030.1771image
chr12:121331840-121335482:-LGGGSVA_HALLMARK_BILE_ACID_METABOLISMEER4.1839e-030.1767image
ENSG00000089053.11,ANAPC5LUADGSVA_HALLMARK_BILE_ACID_METABOLISMEAG4.7777e-030.2917image
chr12:121331840-121335482:-LUADGSVA_HALLMARK_BILE_ACID_METABOLISMEER2.5373e-020.2499image
chr12:121331840-121335482:-LUSCGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEER4.6029e-020.2063image
ENSG00000089053.11,ANAPC5LUSCGSVA_HALLMARK_MITOTIC_SPINDLEEAG1.3382e-030.2850image
chr12:121331840-121335482:-OVGSVA_HALLMARK_FATTY_ACID_METABOLISMEER1.2082e-020.2131image
chr12:121311596-121312817:-OVGSVA_HALLMARK_MITOTIC_SPINDLEEER3.9213e-02-0.2355image
ENSG00000089053.11,ANAPC5OVGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSEEAG1.8803e-02-0.1850image
ENSG00000089053.11,ANAPC5PCPGGSVA_HALLMARK_HEDGEHOG_SIGNALINGEAG2.8797e-020.4661image
chr12:121331840-121335482:-PCPGGSVA_HALLMARK_HEDGEHOG_SIGNALINGEER2.8797e-020.4661image
ENSG00000089053.11,ANAPC5PRADGSVA_HALLMARK_PANCREAS_BETA_CELLSEAG2.9943e-020.2716image
chr12:121331840-121335482:-PRADGSVA_HALLMARK_PANCREAS_BETA_CELLSEER4.0631e-020.2745image
ENSG00000089053.11,ANAPC5SKCMGSVA_HALLMARK_PEROXISOMEEAG9.6099e-03-0.3432image
chr12:121331840-121335482:-SKCMGSVA_HALLMARK_PEROXISOMEEER9.8628e-03-0.3582image
chr12:121338457-121339588:-STADGSVA_HALLMARK_COAGULATIONEER6.1308e-030.4024image
ENSG00000089053.11,ANAPC5STADGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEAG2.7364e-050.2645image
chr12:121331840-121335482:-STADGSVA_HALLMARK_UV_RESPONSE_UPEER2.0274e-060.3119image
chr12:121311596-121312817:-STADGSVA_HALLMARK_APOPTOSISEER2.8034e-020.2067image
ENSG00000089053.11,ANAPC5TGCTGSVA_HALLMARK_PROTEIN_SECRETIONEAG1.7905e-02-0.4789image
ENSG00000089053.11,ANAPC5THYMGSVA_HALLMARK_PI3K_AKT_MTOR_SIGNALINGEAG1.8969e-02-0.4957image
chr12:121331840-121335482:-THYMGSVA_HALLMARK_PI3K_AKT_MTOR_SIGNALINGEER4.0395e-02-0.4618image


Top

7. Enriched editing regions and drugs for ANAPC5


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
ENSG00000089053.11,ANAPC5BLCALenalidomideEAG1.9446e-020.3398image
chr12:121331840-121335482:-BLCALenalidomideEER4.1166e-030.4862image
chr12:121331840-121335482:-BRCALenalidomideEER1.9892e-020.1422image
ENSG00000089053.11,ANAPC5BRCALenalidomideEAG7.7651e-030.1539image
chr12:121331840-121335482:-CESCAxitinibEER2.8249e-020.4387image
ENSG00000089053.11,ANAPC5CESCAxitinibEAG1.8495e-020.3755image
ENSG00000089053.11,ANAPC5ESCABMS.708163EAG2.3820e-020.1959image
chr12:121311596-121312817:-ESCAGefitinibEER3.6711e-02-0.2325image
chr12:121331840-121335482:-ESCAAZD6244EER2.6590e-02-0.2008image
chr12:121313191-121314913:-ESCADasatinibEER5.5978e-03-0.3506image
ENSG00000089053.11,ANAPC5GBMAZD.0530EAG2.4160e-020.3516image
ENSG00000089053.11,ANAPC5KIRCLapatinibEAG1.4864e-05-0.3856image
chr12:121331840-121335482:-KIRCAG.014699EER1.9536e-030.2884image
ENSG00000089053.11,ANAPC5KIRPEHT.1864EAG9.4593e-030.3469image
chr12:121331840-121335482:-LAMLLenalidomideEER1.9170e-050.3435image
ENSG00000089053.11,ANAPC5LAMLLenalidomideEAG7.7256e-060.3561image
chr12:121313191-121314913:-LAMLCisplatinEER2.1413e-02-0.2322image
ENSG00000089053.11,ANAPC5LGGJNK.Inhibitor.VIIIEAG8.6694e-040.2049image
chr12:121331840-121335482:-LGGJNK.Inhibitor.VIIIEER8.6462e-040.2050image
chr12:121331840-121335482:-LUADLapatinibEER8.3928e-03-0.2928image
ENSG00000089053.11,ANAPC5LUADBI.D1870EAG9.2596e-030.2699image
chr12:121331840-121335482:-LUSCBortezomibEER3.1867e-02-0.2216image
ENSG00000089053.11,ANAPC5LUSCCCT007093EAG5.3235e-03-0.2488image
chr12:121331840-121335482:-OVMethotrexateEER8.0389e-030.2248image
chr12:121311596-121312817:-OVABT.263EER1.4865e-030.3560image
ENSG00000089053.11,ANAPC5OVMethotrexateEAG3.1837e-030.2311image
chr12:121331840-121335482:-PRADBMS.509744EER1.0325e-02-0.3401image
ENSG00000089053.11,ANAPC5PRADBMS.509744EAG3.0012e-02-0.2715image
ENSG00000089053.11,ANAPC5SARCCisplatinEAG2.1644e-020.3578image
chr12:121331840-121335482:-SARCGNF.2EER2.6076e-02-0.3473image
ENSG00000089053.11,ANAPC5SKCMGW843682XEAG3.8118e-02-0.2779image
chr12:121331840-121335482:-SKCMGW843682XEER3.2222e-02-0.3004image
chr12:121331840-121335482:-STADCEP.701EER1.7057e-02-0.1596image
ENSG00000089053.11,ANAPC5STADGefitinibEAG2.8830e-020.1400image
chr12:121313191-121314913:-STADIPA.3EER1.9227e-020.2663image
chr12:121338457-121339588:-STADAZD6482EER1.2763e-03-0.4654image
chr12:121311596-121312817:-STADBMS.509744EER5.0779e-03-0.2619image
chr12:121331840-121335482:-THCAElesclomolEER1.8635e-020.2008image
ENSG00000089053.11,ANAPC5THCAElesclomolEAG1.9509e-020.1994image
ENSG00000089053.11,ANAPC5THYMBosutinibEAG4.9154e-02-0.4241image
chr12:121331840-121335482:-THYMCGP.082996EER2.0664e-020.5132image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType